Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QQUXG
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
SMP-656
|
|||||
| Synonyms |
SMP656; SMP 656
Click to Show/Hide
|
|||||
| Organization |
Xiling Lab Pharmaceutical Co., Ltd
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 3 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Clinical candidate
Gastric cancer [ICD11:2B72]
Clinical candidate
Lung cancer [ICD11:2C25]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Eribulin
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Unique hydrophilic Linker
|
Linker Info | ||||
| Conjugate Type |
SuperHydra link-on technology.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.